Unlock stock picks and a broker-level newsfeed that powers Wall Street.
425.00
-39.60
(-8.52%)
At close: April 4 at 4:59:38 PM GMT+2
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
129,002
129,002
154,146
176,860
107,901
Investing Cash Flow
-43,494
-43,494
-40,831
-56,046
-24,683
Financing Cash Flow
-105,715
-105,715
-2,925
-69,012
-26,037
End Cash Position
296,146
296,146
316,571
209,025
150,109
Capital Expenditure
-43,531
-43,531
-40,816
-55,916
-24,622
Issuance of Debt
320
320
--
433
168
Repayment of Debt
--
--
-14
--
--
Free Cash Flow
85,471
85,471
113,330
120,944
83,279
6/30/2021 - 12/18/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GN.CO GN Store Nord A/S
91.18
-8.38%
AMBU-B.CO Ambu A/S
108.20
-1.23%
DEMANT.CO Demant A/S
216.80
-2.61%
SMSMED.CO Scandinavian Medical Solutions A/S
4.1300
+3.25%
LAB Standard BioTools Inc.
1.0700
0.00%
GNNDY GN Store Nord A/S
39.75
-0.38%
GETI-B.ST Getinge AB (publ)
194.50
-5.31%
MXCT MaxCyte, Inc.
2.4500
-5.77%
RPID Rapid Micro Biosystems, Inc.
2.1900
-14.12%
CLPT ClearPoint Neuro, Inc.
11.03
-9.11%